CHRISTINE LIGHTFOOT: Open Payments
NPI 1457507352 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 27 payments from 16 companies in 2025. Trend: 2023 $472 · 2024 $3,658 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $170 |
| Exact Sciences Corporation | 3 | $131 |
| Lilly USA, LLC | 3 | $88 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| PFIZER INC. | 2 | $44 |
| Indivior Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
| ViiV Healthcare Company | 1 | $25 |
Products named: Wegovy, The Cologuard Plus Collection Kit, ZEPBOUND, INGREZZA, PREVNAR 20, Cologuard Collection Kit, SHINGRIX, SUBLOCADE.
Industry payments across MO — which companies pay providers there.
